PTGS2 and nasopharyngeal carcinoma: To date, researchers have investigated the associations of many biomarkers with the occurrence, progression and metastasis of NPC, including EBV-LMP1[59–61], EGFR[51, 62, 63], COX-2[41, 64–68], VEGF[69–73], etc [74–81].